Report Link:
Report Link:
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Posted On: 2021-02-23 05:58:19 (Time Zone: Arizona, USA)


EY report, "Moving the needle: Healthcare industry in a post-COVID world", released today at BioAsia 2021 - one of global Life-sciences & Health-tech conventions.

Report Link: Moving the needle: Healthcare industry in a post-COVID world (ey.com)

It is imperative that India reevaluates its current role within the global life sciences industry. It must explore possibilities to consolidate and strengthen its position considering geopolitical and economic shifts. It must attain self-sufficiency as a globally competitive pharmaceutical industry with innovation as a guiding principle for future growth. As the Indian life sciences industry develops its future growth strategy, it is the right time to assess our current position globally and identify key focus areas. EY report in collaboration with BioAsia explores the industry's current and future potential and aims to identify areas where we need to 'Move the Needle' immediately. It captures unique insights of EY Life sciences industry leaders on key priorities of how the industry could prepare for new realities in post pandemic world. It aims to drive understanding of the changing care needs of patients / consumers by building collaborative solutions encompassing industry stakeholders across the value chain.

Speaking at the event:

Sriram Shrinivasan, Global Generics and National Health and Lifesciences Leader, EY, says: "India needs to adopt a 'moonshot' approach to develop and launch innovative drugs. We need to take a target on the number of new chemical and biological entities we need to launch in the next 10 years and go after creating the enabling ecosystem for it. Once an enabling ecosystem is in place, it will create a virtuous cycle and this sector would be more than self-sufficient. Lot of venture funds would automatically come in and a thriving environment would be created. India also needs to leverage its twin strengths in IT and BioTech to create a differentiated proposition and compete in the world."

Kaivaan Movdawalla, Partner, Healthcare, EY India, says: "It is this data which will be the bedrock of the health system that will revolutionise advancement of products, techniques, diagnosis and therapies for providers, med tech and pharma players and aid public health / epidemiological planning. The power of data that can be unleashed by digital capabilities is unimaginable which can be consolidated, analysed and leveraged for better /sharper intelligence and insights for research and development.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on Monsoon outlook

ADD on Wipro - Improving growth visibility - HDFC Securities

Building Materials 4QFY21 Results Preview - Strong demand to support robust margin - HDFC Securities

Consumer Discretionary 4QFY21 Results Preview - Bargains few and far between - HDFC Securities

Consumer Durables 4QFY21 Results Preview - HDFC Securities

Wipro - Q4FY21 Result Update - YES Securities

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on March 2021 Monthly Trade Balance

Wipro - Q4FY21 Result Update - Lofty multiples leave limited margin of safety - ICICI Securities

FMCG & Alco Bev 4QFY21 Results Preview - HDFC Securities

Maintain BUY on Infosys - Q4FY21 Results Review - Buy the dip - HDFC Securities

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on March 2021 WPI Data released today

Non-leveraged financials 4QFY21 Results Preview - HDFC Securities

Infosys - A reality check! - ICICI Securities

Infosys - Q4FY21 Result Update - YES Securities

Polymer price tracker - PVC prices continue to rise - April 15, 2021 - ICICI Securities

Bharti Airtel - Restructuring aimed at digital biz, AGR-tax efficiency - ICICI Securities

Astral Limited - On a strong footing; top pick in pipes - ICICI Securities

Q4FY21 Result Update - Infosys - ICICI Direct

Q4FY21 Result Update - Tata Consultancy Services - ICICI Direct

Company Update - Coforge Ltd - ICICI Direct

Tata Consultancy Services - Q4FY21 Result Update - ICICI Securities

Company Update - Ambuja Cement - ICICI Direct

Banks & NBFCs 4QFY21 Results Preview - HDFC Securities

ADD on Tata Consultancy Services - Strong progression - HDFC Securities

YES SECURITIES on Tata Consultancy Services Q4 FY21 results

Suman Chowdhury, Chief Analytical Officer - Acuité Ratings, on IIP data released on April 12, 2021

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on March 2021 CPI Data

Q4FY21 Result Preview - Retail - ICICI Direct

Q4FY21 Result Preview - Auto and auto ancillary - ICICI Direct

Monetary Policy Update - April 2021 - ICICI Direct

Q4FY21 Result Preview - Banking & Financial Services - ICICI Direct

It would have helped if the sector received benefit from MPC: Realtors

Views on RBI Policy - April 7, 2021 - Ms. Bekxy Kuriakose, Head - Fixed Income, Principal Asset Management

Mr. Rajiv Sabharwal, MD and CEO, Tata Capital on the RBI's Monetary Policy announcement today

Realtors expected more from RBI MPC

Comments on RBI MPC announcement from Muthoot Finance, Creditas Solutions, Kotak Mahindra Bank

MPC announcement - April 7, 2021 - Acuité Ratings & Research

Views on RBI Policy - April 7, 2021 - Mr. Dhiraj Relli, MD &CEO, HDFC Securities

Dr. Samantak Das, Chief Economist and Head of Research & REIS, JLL India on RBI monetary policy

RBI Monetary Policy - April 7, 2021 - Views of Mr. Amar Ambani, YES SECURITIES

Views on RBI Monetary Policy from experts - April 7, 2021

IPO Review - Macrotech Developers Ltd - ICICI Direct

Quant Pick - Apr 6, 2021 - Godrej Consumer Products - ICICI Direct

Quant Pick - Torrent Pharmaceuticals - ICICI Direct

Sobha Ltd - Record quarter for sales bookings - ICICI Securities

ICICI Securities - Telecom - Bharti Airtel's superior execution likely to continue...

Q4FY21 Result Preview - Telecom - ICICI Direct

ICICI Direct - Company Update - Time Technoplast

ICICI Direct - Sector Update - Banking and Financial Services

NTPC - Excellent performance in a challenging environment; sustainable growth ahead - ICICI Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020